Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Cell and Gene Therapy
"Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci
Discerning hype from reality in the longevity field has become tougher than ever as reputable scientists such as Sinclair and pre-eminent institutions like Harvard align themselves with promising but unproven interventions and at times promote and profit from them
Sinclair, when he first arrived as a young postdoctoral student in Dr
PD is characterized by bradykinesia, rigidity, and tremor [5]
Portfolio company RAPT Therapeutics and development partner Shanghai Jeyou Pharmaceutical Co., Ltd announced positive topline data from Jeyou's Phase 2 trial of RPT904 (JYB1904) as monotherapy in chronic spontaneous urticaria (CSU)
